Catherine Eckford - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Catherine Eckford's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Catherine Eckford

Catherine Eckford

Verified

Editorial Assistant, European Pharmaceutical Review

Final Covers

health physical therapywikipedia

Journalist Type

-

Seniority Positions

Industries

Medium Formats

Content

Total articles 1082

  • Eli Lilly releases topline data for new oral GLP-1

    By Catherine Eckford|European Pharmaceutical ReviewVerifiedPosted: 18 April 2025 | Catherine Eckford (European Pharmaceutical Review) | Subject to regulatory approval, the small molecule drug could provide a new treatment option for diabetes and obesity, Eli Lilly’s new data suggests. Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase III trial

    By Catherine Eckford · European Pharmaceutical Review

    Apr. 18, 2025

  • EC Alzheimer’s drug approval marks advancement for EU patients

    By Catherine Eckford|European Pharmaceutical ReviewVerifiedPosted: 16 April 2025 | Catherine Eckford (European Pharmaceutical Review) | Lecanemab is the only approved Aβ monoclonal antibody that highly binds to and clears toxic protofibrils with high selectivity. The European Commission (EC) has granted a marketing authorization for Leqembi®∇ (lecanemab) as the first therapy in the EU targeting an underlying cause of Alzheimer’s. Eisai Co., Ltd

    By Catherine Eckford · European Pharmaceutical Review

    Apr. 16, 2025

As seen in

Company Info

European Pharmaceutical Review

European Pharmaceutical Review is a prominent publication in the pharmaceutical industry, based in the UK. It focuses on drug analysis, formulation, delivery, manufacturing, and regulation, providing a platform for industry professionals to stay informed about the latest developments. The publication features bi-monthly issues that include contributions from leading pharmaceutical scientists and business experts, along with interviews and industry updates. The company offers various advertising and marketing opportunities, including print and digital ads, events, and social media campaigns, aimed at helping businesses connect with key decision-makers in the pharmaceutical and life sciences sectors. European Pharmaceutical Review also maintains a strong digital presence, providing access to news, articles, whitepapers, and webinars on topics such as genetics, chromatography, and drug manufacturing. With a substantial readership and online engagement, it serves as a vital resource for professionals in the industry.

United Kingdom, United Kingdom

+44 19 5956 3311

Founded: 1996